At Novoviah, we make monitoring for rare antigen-specific T cells easy and sensitive for a clinical trial. Arising from our Founder’s 20+ years’ experience researching and studying celiac disease and inflammatory bowel diseases, Novoviah’s break-through foundation product is the proprietary Novole...See more
Headquarter Australia |
Countries of operation Australia |
Year founded 2020 (4 years) |
Funding status Private |
Company type SME |
Business Development Manager
Commercial Operations Director